Epigenetic regulation in chondrogenesis

Acta Medica Okayama

Volumn 64, Issue 3, 2010, Pages 155-161

  Furumatsu, Takayuki ^a   Ozaki, Toshifumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Chondrogenesis; DNA methylation; Epigenetics; Histone acetylation and HAT; Histone deacetylation and HDAC

Indexed keywords

HISTONE; SIGNAL PEPTIDE;

ACETYLATION; ANIMAL; CHONDROGENESIS; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW;

ACETYLATION; ANIMALS; CHONDROGENESIS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

EUKARYOTA;

EID: 77954743977     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Kragl M, Knapp D, Nacu E, Khattak S, Maden M, Epperlein HH and Tanaka EM: Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature (2009) 460: 60-65.
2. Jones PA and Takai D: The role of DNA methylation in mammalian epigenetics. Science (2001) 293: 1068-1070.
3. Quina AS, Buschbeck M and Di Croce L: Chromatin structure and epigenetics. Biochem Pharmacol (2006) 72: 1563-1569.
4. Reik W, Dean W and Walter J: Epigenetic reprogramming in mammalian development. Science (2001) 293: 1089-1093.
5. Okano M, Bell DW, Haber DA and Li E: DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 99: 247-257.
6. Wolffe AP and Hayes JJ: Chromatin disruption and modification. Nucleic Acids Res (1999) 27: 711-720.
7. Strahl BD and Allis CD: The language of covalent histone modifications. Nature (2000) 403: 41-45.
8. Ko M, Sohn DH, Chung H and Seong RH: Chromatin remodeling, development and disease. Mutat Res (2008) 647: 59-67.
9. Jenuwein T and Allis CD: Translating the histone code. Science (2001) 293: 1074-1080.
10. Akiyama H, Chaboissier MC, Martin JF, Schedl A and de Crombrugghe B: The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev (2002) 16: 2813-2828.
11. Stricker S, Fundele R, Vortkamp A and Mundlos S: Role of Runx genes in chondrocyte differentiation. Dev Biol (2002) 245: 95-108.
12. Shi Y and Massagué J: Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell (2003) 113: 685-700.
13. Kamachi Y, Uchikawa M and Kondoh H: Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet (2000) 16: 182-187.
14. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, Wolf U, Tommerup N, Schempp W and Scherer G: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 79: 1111-1120.
15. Bi W, Deng JM, Zhang Z, Behringer RR and de Crombrugghe B: Sox9 is required for cartilage formation. Nat Genet (1999) 22: 85-89.
16. Zhao Q, Eberspaecher H, Lefebvre V and de Crombrugghe B: Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn (1997) 209: 377-386.
17. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD and de Crombrugghe B: Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev (2004) 18: 1072-1087.
18. Liu F: Receptor-regulated Smads in TGF-β signaling. Front Biosci (2003) 8: s1280-1303.
19. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284: 143-147.
20. Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier RN and O'Keefe RJ: Smad2 and 3 mediate transforming growth factor-β1-induced inhibition of chondrocyte maturation. Endocrinology (2000) 141: 4728-4735.
21. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K and Nishida E: Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-(-induced gene expression. J Biol Chem (1999) 274: 27161-27167.
22. Furumatsu T, Ozaki T and Asahara H: Smad3 activates the Sox9-dependent transcription on chromatin. Int J Biochem Cell Biol (2009) 41: 1198-1204.
23. Alliston T, Choy L, Ducy P, Karsenty G and Derynck R: TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J (2001) 20: 2254-2272.
24. Liu D, Black BL and Derynck R: TGF-β inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev (2001) 15: 2950-2966.
25. Nishihara A, Hanai JI, Okamoto N, Yanagisawa J, Kato S, Miyazono K and Kawabata M: Role of p300, a transcriptional coactivator, in signalling of TGF-β Genes Cells (1998) 3: 613-623.
26. Li E: Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet (2002) 3: 662-673.
27. Jaenisch R and Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 33: Suppl. 245-254.
28. Felsenfeld G and Groudine M: Controlling the double helix. Nature (2003) 421: 448-453.
29. Bird AP and Wolffe AP: Methylation-induced repression--belts, braces, and chromatin. Cell (1999) 99: 451-454.
30. Ezura Y, Sekiya I, Koga H, Muneta T and Noda M: Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum (2009) 60: 1416-1426.
31. Aoyama T, Okamoto T, Nagayama S, Nishijo K, Ishibe T, Yasura K, Nakayama T, Nakamura T and Toguchida J: Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. J Biol Chem (2004) 279: 28789-28797.
32. Fernández MP, Young MF and Sobel ME: Methylation of type II and type I collagen genes in differentiated and dedifferentiated chondrocytes. J Biol Chem (1985) 260: 2374-2378.
33. Zimmermann P, Boeuf S, Dickhut A, Boehmer S, Olek S and Richter W: Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum (2008) 58: 2743-2753.
34. Egger G, Liang G, Aparicio A and Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 429: 457-463.
35. Roach HI and Aigner T: DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage (2007) 15: 128-137.
36. Pöschl E, Fidler A, Schmidt B, Kallipolitou A, Schmid E and Aigner T: DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis (2005) 64: 477-480.
37. Roth SY, Denu JM and Allis CD: Histone acetyltransferases. Annu Rev Biochem (2001) 70: 81-120.
38. Sterner DE and Berger SL: Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev (2000) 64: 435-459.
39. Chan HM and La Thangue NB: p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci (2001) 114: 2363-2373.
40. Tsuda M, Takahashi S, Takahashi Y and Asahara H: Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem (2003) 278: 27224-27229.
41. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, Ito T and Asahara H: Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem (2005) 280: 35203-35208.
42. Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA and Hanley NA: Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem (2008) 283: 14063-14071.
43. Iioka T, Furukawa K, Yamaguchi A, Shindo H, Yamashita S and Tsukazaki T: P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain. J Bone Miner Res (2003) 18: 1419-1429.
44. Liu CJ, Zhang Y, Xu K, Parsons D, Alfonso D and Di Cesare PE: Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators. Front Biosci (2007) 12: 3899-3910.
45. Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N and Di Cesare PE: Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem (2004) 279: 47081-47091.
46. Hattori T, Coustry F, Stephens S, Eberspaecher H, Takigawa M, Yasuda H and de Crombrugghe B. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res (2008) 36: 3011-3024.
47. Furumatsu T, Shukunami C, Amemiya-Kudo M, Shimano H and Ozaki T: Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int J Biochem Cell Biol (2010) 42: 148-156.
48. Shahbazian MD and Grunstein M: Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem (2007) 76: 75-100
49. Haberland M, Montgomery RL and Olson EN: The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet (2009) 10: 32-42.
50. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G and Olson EN: Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell (2004) 119: 555-566.
51. Pei M, Chen D, Li J and Wei L: Histone deacetylase 4 promotes TGF-β1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. Differentiation (2009) 78: 260-268.
52. Huh YH, Ryu JH and Chun JS: Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J Biol Chem (2007) 282: 17123-17131.
53. Hong S, Derfoul A, Pereira-Mouries L and Hall DJ: A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J (2009) 23: 3539-3552.
54. Heng BC, Cao T and Lee EH: Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells (2004) 22: 1152-1167.
55. van der Kraan PM, Blaney Davidson EN, Blom A and van den Berg WB: TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage (2009) 17: 1539-1545.
56. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H: Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem (2005) 280: 8343-8350.
57. Pan Q, Wu Y, Lin T, Yao H, Yang Z, Gao G, Song E and Shen H: Bone morphogenetic protein-2 induces chromatin remodeling and modification at the proximal promoter of Sox9 gene. Biochem Biophys Res Commun (2009) 379: 356-361.
58. Kang JS, Alliston T, Delston R and Derynck R: Repression of Runx2 function by TGF-βthrough recruitment of class II histone deacetylases by Smad3. EMBO J (2005) 24: 2543-2555.
59. Kim DW and Lassar AB: Smad-dependent recruitment of a histone deacetylase/Sin3A complex modulates the bone morphogenetic protein-dependent transcriptional repressor activity of Nkx3.2. Mol Cell Biol (2003) 23: 8704-8717.
60. Furumatsu T: Sox9-dependent transcription in chondrogenesis. J Joint Surg (2008) 27: 146-147 (in Japanese).
61. Furumatsu T: Sox9-related epigenetic regulation. Orthop Surg Trauma (2009) 52: 1040-1041 (in Japanese).